This review discusses the problem of safe, controlled myoplegia during anesthesia in patients with tumors of the maxillofacial area. Anatomical features of this category of patients affecting the permeability of the upper respiratory tract during standard induction of anesthesia are considered. Modern drugs for myoplegia and neuromuscular block reversal are presented. As an illustration, 2 clinical cases of using sugammadex for fast cessation of myorelaxant action in an emergency situation are described. Modern guidelines on safe use of myorelaxants and their antagonists for anesthesia in planned surgeries in maxillofacial oncological surgery are presented.
No takes yet. Share an insight, caveat, or question.
Selina et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: